The Venture Codex Logo

The Venture Codex

Arkin Holdings

11 Hamenofim Str. Building B, 9th floor, Herzliya, 4672562, Israel

Overview

Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcare investments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.

Total investments
13
Lead investments
2
Investments · 12mo
0
Active investors
1

Sector focus

  • Biotechnology
  • Health Care
Visit website

Investment portfolio

  • Honeycomb

    Participated · Series B · May 2024

    Honeycomb uses an AI-driven platform that ingests hundreds of data points—geospatial datasets, aerial imagery, and building history—to price multi-unit residential risks without physical inspections. Its underwriting approach allows the company to offer premiums it says can be up to 40% cheaper for well-maintained buildings compared with traditional carriers. Customers include landlords, condo associations, and HOA boards managing multifamily housing. Honeycomb was co-founded in 2019 by CEO Itai Ben-Zaken and CTO Nimrod Sadot. The company reported it was cash-flow positive and profitable, ending 2025 with $275 million in gross written premium and more than $100 billion in total insured value across 22 states. Management projects crossing $500 million in GWP in the next couple of years as it scales the business.

  • Percepto

    Participated · Series C · Jun 2023

    Percepto, based in Modi’in, Israel and led by CEO Dor Abuhasira, provides Autonomous Inspection & Monitoring (AIM), an end-to-end visual inspection solution powered by autonomous drones, robots and AI. AIM automates the entire visual inspection workflow from data collection to AI-powered analysis and insights, enabling faster detection of gas leaks, overheating and infrastructure deterioration. The platform is used by Fortune 500 customers on six continents, including Siemens Energy, Delek US, companies across Koch Industries and ICL Dead Sea Works. Percepto raised a combined $67M Series C in equity and debt funding, bringing total investment in the company to more than $120M. The round was led by Koch Disruptive Technologies and included new investors Zimmer Partners and one of the largest U.S. energy companies, with participation from existing backers U.S. Venture Partners, Delek US Holdings, Atento Capital, Spider Capital and Arkin Holdings. The company plans to use the funds to expand operations and broaden its business reach while helping customers meet environmental, social and corporate governance (ESG) goals by minimizing safety and environmental risks. Percepto develops a vertically integrated stack of drone hardware and software for autonomous site inspection and monitoring, marketed as AIM. Its product is a "drone-in-a-box" that launches on-demand or on schedule, returns to recharge, and transfers data for analysis. The company hires teams in AI, computer vision, navigation and analytics and acquires compute chips from Nvidia to power its systems. Percepto counts customers in around 10 countries, including ENEL, Florida Power and Light and Verizon. Founded in 2014, it has raised $72.5 million to date and recently closed a $45 million Series B. The company has integrated its Sparrow drones with Boston Dynamics' Spot for complementary inspections and says it expects additional partnerships. CEO Dor Abuhasira said the round will help Percepto "create a category leader." Percepto provides on-site autonomous drone solutions for critical infrastructure and industrial sites via its Drone-in-a-Box (DIB) system. The DIB platform uses computer vision, AI and cloud management to enable real-time detection of threats, safety hazards and anomalies, as well as mapping, 3D modelling and emergency response without human intervention. Its solution targets large-scale enterprises in energy, oil & gas, mining and other heavy industries and is in use in more than ten countries, including deployments with Fortune 500 customers such as Enel. Founded in 2014 and led by CEO Dor Abuhasira, Percepto has raised $27.5M to date following a $15M Series A. The company intends to use the Series A proceeds to scale operations, further expand its international presence and continue research and development. Percepto positions its product to improve security, increase productivity, reduce safety risks and lower operational costs for industrial operators. Percepto develops a small hardware-and-software "little black box" that attaches to drones and runs computer vision on an onboard Nvidia Tegra K1 GPU and camera. The product includes an SDK the company says can save companies roughly 70% of the time needed to develop a new drone application. Percepto started last year in Tel Aviv and currently employs seven people, with plans to grow to 12 or more within six months using the new funding. The company is shifting its focus from consumer hobbyist use toward commercial applications such as inspection and automated filming. Percepto plans to make its software available for free under an open-source license later this year to encourage developer adoption and potential enterprise take-up. Founders Dor Abuhasira and Raviv Raz built the product after noticing gaps in consumer drone footage and believe the system could become a standard commercial platform for drone computer vision.

  • Welcome Homes

    Participated · Series A · Jan 2023

    Welcome Homes was founded in May 2020 by DigitalOcean co‑founders Alec Hartman, Mitch Wainer and Ben Uretsky to let customers design and buy new homes online. The company pivoted from fully custom builds to offering curated, move‑in‑ready home models (launched March 2021) and emphasizes "guaranteed pricing" and a streamlined process from land selection to financing to construction. Welcome operates a capital‑light, "neo‑builder" three‑sided managed marketplace linking buyers, builders and banks and does not hold land or unsold homes on its balance sheet. The service is available in New York, New Jersey, Connecticut, Maryland and Pennsylvania, with construction costs (excluding land) ranging from $596,000 to $1.75 million. Welcome said it "6xed" home sales in 2022 and today has about 40 employees. The company plans to use recent funding to grow headcount, develop proprietary land technology, design new home models and expand into additional U.S. markets. Welcome Homes operates an online home-building, customization and purchasing platform that manages the entire process from land selection to financing and construction. The company’s service promises buyers a brand-new, modern home and claims the ability to complete purchase and move-in within six months. It is currently available in the Tri-State area, including Westchester County, NY, Greenwich, CT, and Bergen and Morris Counties, NJ. Welcome Homes plans to expand into additional U.S. markets. The company is led by CEO and founder Alec Hartman and operates as an online-only residential real estate platform. It raised seed financing to support market expansion and to bolster product, sales and marketing initiatives.

  • Phytolon

    Participated · Series A · Jul 2022

    Phytolon develops natural food colorants through proprietary precision fermentation, producing a palette based on two core pigments—yellow and purple—that yield colors across yellow, orange, red, pink, and purple. Its portfolio includes Beetroot Red, which has received FDA approval pending procedural timing. The company emphasizes cost efficiency, robust supply, and environmental sustainability as differentiators for its fermentation-derived colors. Found in Yokne'am, Israel, Phytolon aims to commercialize its products for CPGs and distribution partners in the U.S. and beyond. Following the $23.6 million Series B, the company plans to allocate proceeds to support sales and scaling of supply and distribution.

  • Eleos Health

    Participated · Series A · Apr 2022

    Eleos builds AI agents and multimodal LLM-powered tools that streamline clinical documentation, surface care insights, and improve patient engagement for behavioral health providers. The company recently launched Eleos Compliance, a clinical documentation improvement (CDI) product that uses agentic AI to flag documentation errors and simplify appeals and accreditation work. Eleos uses the industry’s largest dataset of real-world treatment sessions and claims randomized controlled trial results showing >80% faster progress note submission, doubled client engagement, and 3–4x improved care outcomes versus treatment as usual. The company has more than 120 customer organizations across 30+ U.S. states and reports rapid revenue growth, tripling annual revenue over its first three years and doubling revenue in 2024. Eleos plans to use new funding to expand product offerings, grow its commercial team, hire senior leaders and engineering/data talent, and push into underserved segments—particularly substance use disorder and post-acute behavioral healthcare. Eleos Health develops AI that interprets, analyzes and documents behavioral health conversations using proprietary, behavioral health–specific large language models trained on treatment data and clinical expertise. The system reduces operational burden on providers by automating documentation and surfacing objective insights into evidence-based care and the therapeutic alliance. Leadership teams can scale supervision and training and gain visibility into staff activity, caseloads, performance and population health. The company plans new and enhanced AI solutions for group therapy, compliance automation, case management, concurrent documentation and value‑based care support. Eleos intends to expand its reach to more behavioral health providers and segments, deepen strategic partnerships with EHRs and industry associations, and hire more than 50 people by the end of 2024. It is led by CEO Alon Joffe and is based in Boston and Tel Aviv. Eleos Health provides CareOps Automation solutions that consolidate the behavioral care workflow by automating operational necessities, including documentation and compliance administration, and by delivering session intelligence. Its session intelligence tools generate clinical insights that enable clinicians, providers, and networks to track treatment and progress in a measurable way. The company is led by CEO Alon Joffe and is used by thousands of clinicians across more than 20 national care providers and health plans, including Gaudenzia Home, The Brookline Center for Mental Health, and Coleman Health Services. Eleos has captured more than 6.5 million minutes of treatment to date and is projecting 30 million minutes captured by the end of 2022. The company intends to use the funding to accelerate growth and expand its operations, team, and product. Eleos is based in Boston, MA. Eleos Health develops an AI-powered Speech-to-Insights system that analyzes behavioral health sessions to surface actionable insights for clinicians. Its VoiceAI technology runs securely in the background of sessions and analyzes hundreds of data parameters to accelerate clinical decision-making and personalize care. The company has deployed its solution with over a dozen provider organizations, including Solvista Health, Achieve, Yeshiva University and ReachLink. Eleos plans to use the recent funding to expand sales, marketing, and solution delivery teams needed to meet demand for enterprise software deployments across providers and payors. Founded in 2020 and based in Boston and Tel Aviv, the company has added Dr. David Shulkin to its board. Eleos closed a $6M seed round in 2021.

Team